Page 83 - 2021年17期

[23] 郭志国，辛毅.吲哚美辛直肠给药预防ERCP术后胰腺炎 [32] FENG Y，NAVANEETHAN U，ZHU X，et al. Prophylac-
随机对照试验的 Meta 分析[J].胃肠病学和肝病学杂志， tic rectal indomethacin may be ineffective for preventing
2013，22（4）：317-320. post-endoscopic retrograde cholangiopancreatography
[24] 姜宣羽，钟松阳.吲哚美辛直肠给药预防内镜逆行胰胆管 pancreatitis in general patients：a meta-analysis[J]. Dig En-
造影术后胰腺炎随机对照试验的Meta分析[J].中国基层 dosc，2017，29（3）：272-280.
医药，2019，26（10）：1246-1249. [33] AHMAD D，LOPEZ K T，ESMADI M A，et al. The effect
[25] HE X，ZHENG W，DING Y，et al. Rectal indomethacin is of indomethacin in the prevention of postyendoscopic
protective against pancreatitis after endoscopic retrograde retrograde cholangiopancreatography pancreatitis：a meta-
cholangiopancreatography：systematic review and meta- analysis[J]. Pancreas，2014，43（3）：338-342.
analysis[J]. Gastroenterol Res Pract，2018：9784841. [34] YAGHOOBI M，ROLLAND S，WASCHKE K A，et al.
[26] GARG R，MOHAN B P，KRISHNAMOORTHI R，et al. Meta-analysis：rectal indomethacin for the prevention of
Pre-endoscopic retrograde cholangiopancreatography post-ERCP pancreatitis[J]. Aliment Pharmacol Ther，
（ERCP）administration of rectal indomethacin in unselec- 2013，38（9）：995-1001.
ted patients to reduce post-ERCP pancreatitis：a systematic [35] SETHI S，SETHI N，WADHWA V，et al. A meta-analysis
review and meta-analysis[J]. Indian J Gastroenterol，2018， on the role of rectal diclofenac and indomethacin in the
37（2）：120-126. prevention of post-endoscopic retrograde cholangiopan-
[27] INAMDAR S，HAN D，PASSI M，et al. Rectal indometha- creatography pancreatitis[J]. Pancreas，2014，43（2）：190-
cin is protective against post-ERCP pancreatitis in high- 197.
risk patients but not average-risk patients：a systematic re- [36] VAN DER MERWE J，TRAPP E，PRISTAUZ G，et al.
view and meta-analysis[J]. Gastrointest Endosc，2017，85 Post-ERCP pancreatitis：new momentum[J]. Endoscopy，
（1）：67-75. 2002，34（4）：325-329.
[28] PATAI A，SOLYMOSI N，MOHACSI L，et al. Indometha- [37] VANDERVOORT J，SOETIKNO R M，THAM T C K，
cin and diclofenac in the prevention of post-ERCP pan- et al. Risk factors for complications after performance of
creatitis：a systematic review and meta-analysis of pro- ERCP[J]. Gastrointest Endosc，2002，56（5）：652-656.
spective controlled trials[J]. Gastrointest Endosc，2017，85 [38] NAIK R，YI-CHUN Y，SLATTERY D，et al. Guide wire-
（6）：1144. assisted cannulation for the prevention of post-ERCP pan-
[29] WAN J，REN Y，ZHU Z，et al. How to select patients and creatitis：a systematic review and meta-analysis[J]. Endo-
timing for rectal indomethacin to prevent post-ERCP pan- scopy，2013，45（8）：605-618.
creatitis：a systematic review and meta-analysis[J]. BMC [39] BASSAN M S，HOLT B A，MAHADY S，et al. Guidewire
Gastroenterology，2017，17（1）：43. biliary cannulation does not reduce post-ERCP pancreati-
[30] SHI N，DENG L，ALTAF K，et al. Rectal indomethacin tis compared with the contrast injection technique in low-
for the prevention of post-ERCP pancreatitis：a meta-analy- risk and high-risk patients[J]. Gastrointest Endosc，2012，
sis of randomized controlled trials[J]. Turk J Gastroenterol， 76（1）：339-346.
2015，26（3）：236-240. [40] ELMUNZER B J，SCHEIMAN J M，LEHMAN G A，
[31] YAGHOOBI M，ALZAHRANI M A，MCNABB-BALTAR et al. A randomized trial of rectal indomethacin to prevent
J，et al. Rectal indomethacin prevents moderate to severe post-ERCP pancreatitis[J]. N Engl J Med，2012，366（15）：
post-ERCP pancreatitis and death and should be used be- 1414-1422.
fore the procedure：a meta-analysis of aggregate subgroup （收稿日期：2021-03-04 修回日期：2021-05-13）
data[J]. J Can Assoc Gastroenterol，2018，1（2）：67-75. （编辑：刘明伟）

《中国药房》杂志——中国科技核心期刊，欢迎投稿、订阅

中国药房 2021年第32卷第17期 China Pharmacy 2021 Vol. 32 No. 17 ·2121 ·